INSULIN DEGLUDEC

INSULIN DEGLUDEC was reported 23942 times

INSULIN DEGLUDEC is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPENDICOLITH 268 0.6925
1 HEART SOUNDS 57 0.5938
2 ABDOMINAL TRANSPOSITION 14 0.5185
3 SLEEP DISORDER THERAPY 93 0.4697
4 ANTACID THERAPY 51 0.3923
5 ANALGESIC THERAPY 95 0.2960
6 DRUG THERAPY 93 0.2743
7 PROLONGED EXPIRATION 57 0.2176
8 SCLEROEDEMA 11 0.1897
9 ANTICOAGULANT THERAPY 51 0.1796
10 MEDICAL DEVICE SITE ABSCESS 11 0.1594
11 BACTEROIDES INFECTION 36 0.1379
12 CONGENITAL HIATUS HERNIA 30 0.1316
13 MALIGNANT MELANOMA STAGE 0 27 0.1292
14 BLOOD PHOSPHORUS INCREASED 176 0.0644
15 HYPERPHOSPHATAEMIA 122 0.0567
16 HYPOGLYCAEMIC ENCEPHALOPATHY 21 0.0540
17 HYPOGLYCAEMIC UNCONSCIOUSNESS 89 0.0449
18 GAIT SPASTIC 14 0.0408
19 HYPOGLYCAEMIA UNAWARENESS 14 0.0391
20 ANION GAP ABNORMAL 10 0.0373
21 CORRECTIVE LENS USER 36 0.0370
22 DIABETIC HYPERGLYCAEMIC COMA 12 0.0368
23 DIABETIC METABOLIC DECOMPENSATION 51 0.0367
24 DIABETIC RETINOPATHY 122 0.0359
25 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 32 0.0345
26 APPENDICITIS 278 0.0297
27 TOTAL LUNG CAPACITY DECREASED 47 0.0294
28 JOINT ABSCESS 10 0.0287
29 HYPOGLYCAEMIC SEIZURE 26 0.0286
30 IRON DEFICIENCY 127 0.0282
31 INSULIN RESISTANCE 57 0.0274
32 BLOOD GLUCOSE DECREASED 1309 0.0272
33 GASTROINTESTINAL HYPOMOTILITY 60 0.0266
34 IMPAIRED GASTRIC EMPTYING 362 0.0265
35 BLOOD GLUCOSE FLUCTUATION 284 0.0259
36 BLOOD URIC ACID INCREASED 146 0.0253
37 DIABETES MELLITUS INADEQUATE CONTROL 435 0.0245
38 MUSCLE MASS 11 0.0243
39 PRESBYOPIA 13 0.0234
40 DYSMETRIA 14 0.0232
41 GLYCOSYLATED HAEMOGLOBIN INCREASED 581 0.0230
42 THIRST DECREASED 14 0.0223
43 HYPOGLYCAEMIC COMA 63 0.0218
44 VENTRICULAR FIBRILLATION 231 0.0208
45 HYPOGLYCAEMIA 981 0.0202
46 BLOOD GLUCOSE INCREASED 3805 0.0202
47 DIABETIC NEUROPATHY 99 0.0200
48 CARDIOGENIC SHOCK 283 0.0197
49 OEDEMATOUS PANCREATITIS 11 0.0196
50 CAROTID ARTERIOSCLEROSIS 20 0.0194
51 MYASTHENIA GRAVIS 156 0.0193
52 BLOOD KETONE BODY INCREASED 15 0.0192
53 DIABETIC KETOACIDOSIS 453 0.0188
54 NEUROPATHIC ARTHROPATHY 12 0.0185
55 KETOSIS 20 0.0184
56 AORTIC STENOSIS 64 0.0184
57 BLOOD INSULIN INCREASED 10 0.0181
58 HYPOPHOSPHATAEMIA 134 0.0181
59 EUGLYCAEMIC DIABETIC KETOACIDOSIS 72 0.0174
60 LUNG OPACITY 45 0.0171
61 CONGENITAL CARDIOVASCULAR ANOMALY 14 0.0167
62 OBSTRUCTIVE SLEEP APNOEA SYNDROME 24 0.0164
63 DEPRESSIVE SYMPTOM 58 0.0164
64 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 77 0.0152
65 DEVICE LOOSENING 13 0.0150
66 PRODUCT APPEARANCE CONFUSION 13 0.0141
67 RALES 81 0.0139
68 DIABETIC FOOT 41 0.0134
69 BLOOD GLUCOSE ABNORMAL 246 0.0133
70 DIABETIC COMA 37 0.0132
71 DIABETIC FOOT INFECTION 18 0.0127
72 GLYCOSYLATED HAEMOGLOBIN DECREASED 19 0.0118
73 RETINOPATHY 44 0.0118
74 APPETITE DISORDER 76 0.0115
75 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 12 0.0113
76 TROPONIN INCREASED 85 0.0112
77 FOOT AMPUTATION 16 0.0110
78 CATARACT OPERATION 65 0.0109
79 HYPERGLYCAEMIA 396 0.0109
80 DEVICE FAILURE 165 0.0108
81 HYPOGLYCAEMIA NEONATAL 17 0.0105
82 MULTIPLE ORGAN DYSFUNCTION SYNDROME 295 0.0104
83 ASCITES 305 0.0104
84 KETOACIDOSIS 75 0.0100
85 SHOULDER FRACTURE 16 0.0098
86 WRONG PRODUCT ADMINISTERED 66 0.0098
87 AMPUTATION 12 0.0096
88 PANCREATIC FAILURE 17 0.0096
89 PLEURITIC PAIN 26 0.0094
90 RESPIRATION ABNORMAL 64 0.0093
91 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 11 0.0092
92 BLOOD CALCIUM INCREASED 80 0.0091
93 BACTERIAL INFECTION 159 0.0085
94 URINE KETONE BODY PRESENT 13 0.0082
95 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 141 0.0082
96 DRUG DISPENSING ERROR 125 0.0082
97 GLUCOSE URINE PRESENT 10 0.0079
98 ACCIDENTAL UNDERDOSE 112 0.0078
99 ESSENTIAL HYPERTENSION 14 0.0076
100 DRUG DELIVERY SYSTEM ISSUE 15 0.0076
101 WRONG PATIENT RECEIVED PRODUCT 22 0.0075
102 BENIGN PROSTATIC HYPERPLASIA 38 0.0074
103 FLANK PAIN 67 0.0071
104 HYPERLIPIDAEMIA 85 0.0071
105 PANCREATIC DISORDER 35 0.0071
106 RESPIRATORY SYMPTOM 20 0.0070
107 LIVING IN RESIDENTIAL INSTITUTION 13 0.0069
108 DIABETIC NEPHROPATHY 15 0.0068
109 HYPERPARATHYROIDISM SECONDARY 17 0.0068
110 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 115 0.0068
111 PANCREATITIS CHRONIC 16 0.0068
112 TOE AMPUTATION 34 0.0067
113 NEURALGIA 157 0.0065
114 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 26 0.0064
115 END STAGE RENAL DISEASE 111 0.0061
116 LIQUID PRODUCT PHYSICAL ISSUE 44 0.0060
117 INJECTION SITE SCAR 17 0.0060
118 EYE OPERATION 27 0.0059
119 CHOLESTATIC LIVER INJURY 13 0.0058
120 LISTLESS 19 0.0058
121 CHRONIC GASTRITIS 13 0.0058
122 PERIARTHRITIS 13 0.0057
123 PANCREATIC CARCINOMA METASTATIC 16 0.0056
124 NEPHROGENIC ANAEMIA 26 0.0056
125 RENAL TRANSPLANT 20 0.0055
126 HYPONATRAEMIA 310 0.0055
127 DIABETIC COMPLICATION 14 0.0055
128 TYPE 1 DIABETES MELLITUS 33 0.0055
129 EYELID PAIN 11 0.0054
130 BREATH SOUNDS ABNORMAL 26 0.0053
131 GOUT 93 0.0052
132 LIPODYSTROPHY ACQUIRED 11 0.0052
133 NECROTISING FASCIITIS 18 0.0051
134 LEG AMPUTATION 21 0.0051
135 MYOPIA 12 0.0050
136 ALLERGIC REACTION TO EXCIPIENT 10 0.0050
137 ULCER 78 0.0049
138 SHOULDER ARTHROPLASTY 13 0.0048
139 GANGRENE 29 0.0048
140 MULTIPLE USE OF SINGLE-USE PRODUCT 27 0.0048
141 DIABETES MELLITUS 359 0.0047
142 PRURITUS GENITAL 11 0.0047
143 ABDOMINAL DISTENSION 487 0.0047
144 URINE ABNORMALITY 21 0.0046
145 INCORRECT DOSE ADMINISTERED BY DEVICE 117 0.0045
146 MACULAR DEGENERATION 52 0.0044
147 TOXIC ENCEPHALOPATHY 22 0.0043
148 PRODUCT COMMUNICATION ISSUE 38 0.0043
149 PRODUCT LEAKAGE 24 0.0043
150 VISUAL IMPAIRMENT 522 0.0042
151 ASPIRATION 46 0.0042
152 CARDIAC OPERATION 36 0.0042
153 THYROID MASS 16 0.0042
154 BLOOD TEST ABNORMAL 58 0.0041
155 SPINAL STENOSIS 17 0.0041
156 HUNGER 57 0.0041
157 WRONG DRUG ADMINISTERED 36 0.0040
158 HYPERPHAGIA 16 0.0040
159 BLOOD CHOLESTEROL INCREASED 187 0.0040
160 CATARACT 238 0.0040
161 HYPOACUSIS 172 0.0040
162 ABSCESS LIMB 17 0.0040
163 INFUSION SITE HAEMORRHAGE 13 0.0039
164 BLOOD POTASSIUM INCREASED 64 0.0039
165 DISABILITY 76 0.0038
166 PEMPHIGOID 29 0.0038
167 CAROTID ARTERY OCCLUSION 14 0.0038
168 INJECTION SITE EXTRAVASATION 47 0.0038
169 ERYSIPELAS 19 0.0038
170 THIRST 67 0.0037
171 NEPHROPATHY 35 0.0037
172 CORONARY ARTERY OCCLUSION 51 0.0037
173 IMMUNE THROMBOCYTOPENIA 17 0.0037
174 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 193 0.0037
175 SEPSIS 409 0.0037
176 FOETAL DEATH 19 0.0037
177 WALKING AID USER 24 0.0036
178 NEAR DEATH EXPERIENCE 12 0.0036
179 ONYCHOCLASIS 25 0.0036
180 PRODUCT DISPENSING ERROR 79 0.0036
181 ERUCTATION 70 0.0036
182 PRE-ECLAMPSIA 17 0.0036
183 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 22 0.0036
184 LOCALISED INFECTION 85 0.0035
185 MICTURITION URGENCY 40 0.0035
186 BLOOD MAGNESIUM DECREASED 30 0.0035
187 EYE HAEMORRHAGE 46 0.0034
188 DEMENTIA 96 0.0034
189 HEPATIC ENCEPHALOPATHY 32 0.0034
190 AUTONOMIC NERVOUS SYSTEM IMBALANCE 10 0.0034
191 HYPERCHOLESTEROLAEMIA 33 0.0034
192 FULL BLOOD COUNT ABNORMAL 36 0.0034
193 CONSTIPATION 733 0.0034
194 ANKLE FRACTURE 52 0.0034
195 IRON DEFICIENCY ANAEMIA 31 0.0034
196 BLINDNESS UNILATERAL 47 0.0033
197 GENERAL PHYSICAL HEALTH DETERIORATION 382 0.0033
198 NEUROPATHY PERIPHERAL 314 0.0033
199 CARDIAC FAILURE CHRONIC 14 0.0033
200 PRODUCT DISPENSING ISSUE 14 0.0033
201 BRONCHIECTASIS 22 0.0033
202 HYPERKERATOSIS 18 0.0033
203 DEVICE MALFUNCTION 229 0.0033
204 DRY MOUTH 262 0.0032
205 MACULAR OEDEMA 18 0.0032
206 LIMB INJURY 87 0.0032
207 ARTERIAL OCCLUSIVE DISEASE 25 0.0032
208 SPUTUM DISCOLOURED 30 0.0032
209 WEIGHT FLUCTUATION 33 0.0032
210 BLADDER PAIN 10 0.0031
211 INCREASED APPETITE 60 0.0031
212 COVID-19 PNEUMONIA 37 0.0031
213 HYPOVOLAEMIC SHOCK 15 0.0031
214 CORONARY ARTERY BYPASS 18 0.0031
215 SKIN ATROPHY 18 0.0031
216 DRUG PRESCRIBING ERROR 60 0.0031
217 MUSCLE RUPTURE 12 0.0031
218 ANGINA PECTORIS 88 0.0031
219 ABDOMINAL HERNIA 14 0.0031
220 THERAPEUTIC PRODUCT EFFECT DELAYED 14 0.0031
221 HEPATIC STEATOSIS 57 0.0031
222 BLINDNESS 124 0.0030
223 TASTE DISORDER 61 0.0030
224 SLEEP DISORDER 212 0.0030
225 OSTEOMYELITIS 54 0.0030
226 NERVE INJURY 33 0.0030
227 SKIN ABRASION 14 0.0030
228 TENDON INJURY 11 0.0030
229 CHOLECYSTITIS 35 0.0029
230 MENISCUS INJURY 18 0.0029
231 LOWER RESPIRATORY TRACT INFECTION 133 0.0029
232 PRODUCT LABEL CONFUSION 17 0.0029
233 PRODUCT STORAGE ISSUE 11 0.0029
234 HUMERUS FRACTURE 14 0.0029
235 ILEUS 36 0.0029
236 SWELLING 271 0.0029
237 ANAL INCONTINENCE 26 0.0029
238 INJECTION SITE INJURY 16 0.0029
239 DYSPNOEA EXERTIONAL 108 0.0029
240 GLAUCOMA 55 0.0029
241 HOSPICE CARE 28 0.0028
242 POST PROCEDURAL INFECTION 23 0.0028
243 PANCREATITIS 149 0.0028
244 POOR PERIPHERAL CIRCULATION 12 0.0028
245 UPPER RESPIRATORY TRACT INFECTION 130 0.0028
246 THROMBOSIS 226 0.0028
247 RETINAL HAEMORRHAGE 20 0.0028
248 BRAIN FOG 44 0.0028
249 SOPOR 37 0.0028
250 HEPATIC CIRRHOSIS 52 0.0028
251 GLOMERULAR FILTRATION RATE DECREASED 34 0.0028
252 SEASONAL ALLERGY 39 0.0028
253 INJURY ASSOCIATED WITH DEVICE 56 0.0027
254 ACIDOSIS 21 0.0027
255 BODY TEMPERATURE DECREASED 27 0.0027
256 INJECTION SITE MASS 101 0.0027
257 CHRONIC KIDNEY DISEASE 207 0.0027
258 JOINT INJURY 58 0.0027
259 CYSTIC FIBROSIS 15 0.0027
260 SKIN ULCER 70 0.0027
261 WHEEZING 159 0.0027
262 ARTHRITIS BACTERIAL 11 0.0027
263 ACUTE PULMONARY OEDEMA 15 0.0027
264 ARTERIOSCLEROSIS 25 0.0027
265 ROTATOR CUFF SYNDROME 34 0.0026
266 ABDOMINAL PAIN 611 0.0026
267 ACUTE KIDNEY INJURY 400 0.0026
268 WEIGHT INCREASED 582 0.0026
269 MALNUTRITION 29 0.0026
270 INTENTIONAL PRODUCT MISUSE 226 0.0026
271 CHOLANGITIS 16 0.0026
272 HEPATIC PAIN 11 0.0026
273 PURULENT DISCHARGE 11 0.0026
274 LIVER FUNCTION TEST INCREASED 55 0.0026
275 BLOOD POTASSIUM DECREASED 77 0.0026
276 PULMONARY MASS 38 0.0025
277 HYPOPHAGIA 65 0.0025
278 FLUID RETENTION 129 0.0025
279 PRODUCT STORAGE ERROR 220 0.0025
280 RETINAL DETACHMENT 23 0.0025
281 LIMB OPERATION 12 0.0025
282 PANCREATITIS ACUTE 56 0.0025
283 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 119 0.0025
284 CARDIAC FLUTTER 16 0.0025
285 INJECTION SITE DISCOMFORT 26 0.0025
286 FOOD CRAVING 13 0.0025
287 MUSCLE DISORDER 20 0.0025
288 RENAL DISORDER 115 0.0025
289 ATRIOVENTRICULAR BLOCK 19 0.0025
290 LARGE INTESTINE POLYP 17 0.0025
291 DEHYDRATION 326 0.0024
292 PRODUCTIVE COUGH 116 0.0024
293 COMPRESSION FRACTURE 13 0.0024
294 PYELONEPHRITIS 21 0.0024
295 PERIPHERAL SWELLING 372 0.0024
296 ANAL ABSCESS 13 0.0024
297 STENT PLACEMENT 19 0.0024
298 PANCREATIC CARCINOMA 68 0.0024
299 SPINAL OPERATION 29 0.0024
300 LACTIC ACIDOSIS 76 0.0023
301 RENAL TUBULAR NECROSIS 23 0.0023
302 CONCUSSION 18 0.0023
303 FEEDING DISORDER 47 0.0023
304 ACCIDENTAL OVERDOSE 84 0.0023
305 ARTHROPOD BITE 17 0.0023
306 BLOOD LACTIC ACID INCREASED 12 0.0023
307 RENAL IMPAIRMENT 191 0.0023
308 DIZZINESS POSTURAL 22 0.0023
309 ALTERED STATE OF CONSCIOUSNESS 49 0.0023
310 DEAFNESS 59 0.0023
311 DEVICE DEFECTIVE 39 0.0022
312 METABOLIC DISORDER 13 0.0022
313 OVERWEIGHT 12 0.0022
314 ILLNESS 230 0.0022
315 NASAL CONGESTION 131 0.0022
316 FRUSTRATION TOLERANCE DECREASED 18 0.0022
317 METABOLIC ACIDOSIS 71 0.0022
318 CARPAL TUNNEL SYNDROME 31 0.0022
319 RHINORRHOEA 143 0.0022
320 MUSCULOSKELETAL DISCOMFORT 38 0.0022
321 HEPATIC ENZYME ABNORMAL 11 0.0022
322 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 12 0.0022
323 BLOOD PRESSURE SYSTOLIC INCREASED 43 0.0022
324 INJECTION SITE HAEMORRHAGE 175 0.0022
325 BLOOD IRON DECREASED 26 0.0022
326 DEVICE LEAKAGE 95 0.0022
327 VOMITING 1028 0.0022
328 FALL 726 0.0022
329 BLOOD CREATININE INCREASED 142 0.0022
330 CORONARY ARTERIAL STENT INSERTION 11 0.0022
331 DECREASED APPETITE 503 0.0022
332 PULMONARY EMBOLISM 204 0.0021
333 PHARYNGEAL SWELLING 21 0.0021
334 INCORRECT DOSE ADMINISTERED 488 0.0021
335 SCIATICA 34 0.0021
336 EYE INFECTION 24 0.0021
337 HAND FRACTURE 15 0.0021
338 DEVICE MECHANICAL ISSUE 29 0.0021
339 FUNGAL INFECTION 70 0.0021
340 CARDIAC VALVE DISEASE 12 0.0021
341 EYE DISORDER 69 0.0021
342 PRODUCT USE COMPLAINT 33 0.0021
343 CELLULITIS 105 0.0021
344 POST PROCEDURAL COMPLICATION 40 0.0021
345 ASPHYXIA 17 0.0021
346 EXPIRED PRODUCT ADMINISTERED 69 0.0021
347 TRANSIENT ISCHAEMIC ATTACK 70 0.0021
348 DERMATITIS BULLOUS 15 0.0021
349 INJECTION SITE BRUISING 165 0.0021
350 OBSTRUCTIVE AIRWAYS DISORDER 23 0.0021
351 HYPERTENSIVE CRISIS 23 0.0021
352 CARDIAC FAILURE CONGESTIVE 166 0.0021
353 CARDIAC DISORDER 193 0.0021
354 FOOD POISONING 11 0.0021
355 DIALYSIS 29 0.0020
356 URINE ODOUR ABNORMAL 12 0.0020
357 DRUG INTOLERANCE 196 0.0020
358 LYMPHOEDEMA 14 0.0020
359 EXTRA DOSE ADMINISTERED 82 0.0020
360 LIGAMENT SPRAIN 20 0.0020
361 GASTROINTESTINAL SOUNDS ABNORMAL 10 0.0020
362 CORONARY ARTERY DISEASE 61 0.0020
363 FOOT FRACTURE 38 0.0020
364 ASTHENOPIA 11 0.0020
365 INJECTION SITE DISCOLOURATION 25 0.0020
366 KIDNEY INFECTION 39 0.0020
367 JOINT DISLOCATION 21 0.0020
368 RENAL PAIN 21 0.0020
369 PRODUCT PRESCRIBING ERROR 47 0.0020
370 BACK DISORDER 32 0.0020
371 POLLAKIURIA 82 0.0020
372 ARTERIOSCLEROSIS CORONARY ARTERY 13 0.0020
373 BLOOD PRESSURE ABNORMAL 39 0.0020
374 UPPER LIMB FRACTURE 39 0.0020
375 PLEURAL EFFUSION 119 0.0020
376 NERVE COMPRESSION 18 0.0019
377 CHOLECYSTITIS ACUTE 11 0.0019
378 NAUSEA 1536 0.0019
379 SPINAL COMPRESSION FRACTURE 16 0.0019
380 CEREBRAL INFARCTION 47 0.0019
381 DYSPEPSIA 189 0.0019
382 COVID-19 337 0.0019
383 WRIST FRACTURE 23 0.0019
384 CEREBROVASCULAR ACCIDENT 324 0.0019
385 PRODUCT ODOUR ABNORMAL 20 0.0019
386 SOMNOLENCE 383 0.0019
387 FEBRILE NEUTROPENIA 126 0.0019
388 INSURANCE ISSUE 29 0.0019
389 HEAD INJURY 60 0.0019
390 ABDOMINAL PAIN UPPER 390 0.0019
391 HOSPITALISATION 290 0.0019
392 FLATULENCE 107 0.0019
393 URINARY TRACT INFECTION 321 0.0019
394 HYPERTRIGLYCERIDAEMIA 11 0.0019
395 FACIAL PARALYSIS 16 0.0019
396 LIVER DISORDER 83 0.0019
397 MEMORY IMPAIRMENT 257 0.0019
398 WEIGHT DECREASED 522 0.0019
399 INJECTION SITE DISCHARGE 10 0.0019
400 INFLUENZA 207 0.0019
401 INJECTION SITE INDURATION 24 0.0018
402 GASTROENTERITIS 27 0.0018
403 EYE PAIN 104 0.0018
404 SKIN LACERATION 20 0.0018
405 HAEMODYNAMIC INSTABILITY 14 0.0018
406 VISION BLURRED 251 0.0018
407 ESCHERICHIA INFECTION 15 0.0018
408 ASTHMA 206 0.0018
409 LOWER LIMB FRACTURE 35 0.0018
410 SPINAL OSTEOARTHRITIS 16 0.0018
411 ABSCESS 29 0.0018
412 COLON CANCER 27 0.0018
413 SCAR 31 0.0018
414 ACUTE RESPIRATORY DISTRESS SYNDROME 32 0.0018
415 PRODUCT DOSE OMISSION 118 0.0018
416 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 325 0.0018
417 RENAL FAILURE 239 0.0018
418 DEPRESSED MOOD 95 0.0018
419 INTENTIONAL DOSE OMISSION 51 0.0018
420 WOUND 50 0.0018
421 PRODUCT ADMINISTRATION INTERRUPTED 14 0.0018
422 GENERALISED OEDEMA 22 0.0018
423 POSTOPERATIVE WOUND INFECTION 12 0.0018
424 DRY THROAT 18 0.0018
425 GASTROOESOPHAGEAL REFLUX DISEASE 142 0.0018
426 RENAL CYST 14 0.0018
427 RESTLESS LEGS SYNDROME 32 0.0018
428 HAEMOPTYSIS 49 0.0018
429 HYPOKALAEMIA 81 0.0018
430 CHOLECYSTECTOMY 20 0.0017
431 OEDEMA PERIPHERAL 213 0.0017
432 BACK INJURY 19 0.0017
433 ROAD TRAFFIC ACCIDENT 73 0.0017
434 MUSCULOSKELETAL CHEST PAIN 27 0.0017
435 HYPERSOMNIA 50 0.0017
436 BLOOD THYROID STIMULATING HORMONE INCREASED 16 0.0017
437 UROSEPSIS 16 0.0017
438 HYPERTHYROIDISM 25 0.0017
439 ELECTROLYTE IMBALANCE 20 0.0017
440 SUICIDE ATTEMPT 104 0.0017
441 PRODUCT QUALITY ISSUE 231 0.0017
442 INJECTION SITE PAIN 521 0.0017
443 SPINAL FRACTURE 34 0.0017
444 LIPASE INCREASED 13 0.0017
445 CARDIAC FAILURE 136 0.0017
446 THYROID DISORDER 26 0.0017
447 HIP FRACTURE 54 0.0017
448 HYPOXIA 59 0.0017
449 CONDITION AGGRAVATED 509 0.0017
450 INTESTINAL OBSTRUCTION 63 0.0017
451 SLUGGISHNESS 17 0.0017
452 PRODUCT DOSE OMISSION ISSUE 490 0.0017
453 ORTHOSTATIC HYPOTENSION 29 0.0017
454 MULTIPLE ALLERGIES 13 0.0017
455 MUSCLE ATROPHY 21 0.0017
456 LOSS OF CONSCIOUSNESS 212 0.0017
457 SHOCK 38 0.0017
458 APHONIA 23 0.0016
459 CHOLELITHIASIS 54 0.0016
460 EATING DISORDER 35 0.0016
461 INTENTIONAL UNDERDOSE 12 0.0016
462 BLOOD TRIGLYCERIDES INCREASED 29 0.0016
463 VITAMIN D DECREASED 14 0.0016
464 VITREOUS FLOATERS 16 0.0016
465 ANURIA 14 0.0016
466 HYPERKALAEMIA 57 0.0016
467 MUSCLE STRAIN 14 0.0016
468 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 327 0.0016
469 ABNORMAL LOSS OF WEIGHT 11 0.0016
470 RHINITIS 13 0.0016
471 HYPERHIDROSIS 207 0.0016
472 OCULAR DISCOMFORT 18 0.0016
473 ASPARTATE AMINOTRANSFERASE INCREASED 85 0.0016
474 HAEMORRHAGE 167 0.0016
475 BRAIN INJURY 16 0.0016
476 RETCHING 34 0.0016
477 ACUTE MYOCARDIAL INFARCTION 47 0.0016
478 ACCIDENT 19 0.0016
479 INJECTION SITE URTICARIA 39 0.0016
480 POLYURIA 13 0.0016
481 HICCUPS 13 0.0016
482 LIMB DISCOMFORT 49 0.0016
483 BLOOD PRESSURE DECREASED 105 0.0016
484 HYPOMAGNESAEMIA 22 0.0016
485 PRODUCT PACKAGING ISSUE 15 0.0016
486 TRANSAMINASES INCREASED 35 0.0016
487 PRESYNCOPE 38 0.0016
488 PULMONARY THROMBOSIS 17 0.0016
489 INTENTIONAL OVERDOSE 100 0.0016
490 RIB FRACTURE 32 0.0016
491 INTERVERTEBRAL DISC PROTRUSION 34 0.0016
492 BLOOD PRESSURE INCREASED 237 0.0015
493 MUSCULAR WEAKNESS 176 0.0015
494 TOOTH FRACTURE 17 0.0015
495 METASTASIS 11 0.0015
496 AUTOIMMUNE DISORDER 15 0.0015
497 VITAMIN D DEFICIENCY 15 0.0015
498 PARALYSIS 22 0.0015
499 PRODUCT ADMINISTRATION ERROR 31 0.0015
500 BRAIN NEOPLASM 14 0.0015
501 BEDRIDDEN 20 0.0015
502 DIARRHOEA 982 0.0015
503 SCRATCH 16 0.0015
504 RASH PRURITIC 82 0.0015
505 ARTHRITIS 119 0.0015
506 BLADDER DISORDER 15 0.0015
507 AGRANULOCYTOSIS 28 0.0015
508 GAIT INABILITY 50 0.0015
509 CHEST DISCOMFORT 153 0.0015
510 HYPERTENSION 316 0.0015
511 DECREASED ACTIVITY 16 0.0015
512 PNEUMONIA ASPIRATION 37 0.0015
513 DIVERTICULITIS 41 0.0015
514 INCORRECT PRODUCT ADMINISTRATION DURATION 32 0.0015
515 FAECES DISCOLOURED 32 0.0015
516 DYSPNOEA 835 0.0015
517 DRUG LEVEL DECREASED 15 0.0015
518 ANAEMIA 281 0.0015
519 GASTROINTESTINAL DISORDER 131 0.0015
520 WOUND INFECTION 16 0.0015
521 IMPAIRED QUALITY OF LIFE 21 0.0015
522 VERTIGO 89 0.0015
523 AMNESIA 95 0.0015
524 PULMONARY FIBROSIS 28 0.0015
525 TREMOR 242 0.0015
526 CHEST PAIN 270 0.0015
527 GALLBLADDER DISORDER 26 0.0015
528 HYPOKINESIA 21 0.0014
529 OEDEMA 78 0.0014
530 ATRIAL FIBRILLATION 140 0.0014
531 BOWEL MOVEMENT IRREGULARITY 11 0.0014
532 HAEMATURIA 49 0.0014
533 DEFAECATION URGENCY 10 0.0014
534 INFUSION SITE ERYTHEMA 12 0.0014
535 INCONTINENCE 15 0.0014
536 ABDOMINAL DISCOMFORT 238 0.0014
537 NASOPHARYNGITIS 261 0.0014
538 OSTEOARTHRITIS 60 0.0014
539 SLEEP APNOEA SYNDROME 27 0.0014
540 CLOSTRIDIUM DIFFICILE COLITIS 15 0.0014
541 DISCOMFORT 86 0.0014
542 IMMUNODEFICIENCY 21 0.0014
543 DIZZINESS 702 0.0014
544 SINUS CONGESTION 19 0.0014
545 GASTRITIS 37 0.0014
546 MYOCARDIAL ISCHAEMIA 16 0.0014
547 NOCTURIA 17 0.0014
548 DEVICE DELIVERY SYSTEM ISSUE 38 0.0014
549 TUBULOINTERSTITIAL NEPHRITIS 26 0.0014
550 GASTROENTERITIS VIRAL 25 0.0014
551 PULMONARY OEDEMA 62 0.0014
552 URINARY INCONTINENCE 41 0.0014
553 MUSCLE SPASTICITY 17 0.0014
554 DEVICE ISSUE 124 0.0014
555 MYOCARDIAL INFARCTION 241 0.0014
556 NEEDLE ISSUE 40 0.0014
557 URINE OUTPUT DECREASED 12 0.0014
558 EAR DISCOMFORT 14 0.0014
559 INJECTION SITE NODULE 15 0.0014
560 PREMATURE BABY 41 0.0014
561 NECK PAIN 76 0.0014
562 CONFUSIONAL STATE 219 0.0014
563 POOR VENOUS ACCESS 14 0.0014
564 DERMATITIS ALLERGIC 17 0.0014
565 CYSTITIS 43 0.0013
566 SKIN REACTION 19 0.0013
567 ASTHENIA 507 0.0013
568 SURGERY 79 0.0013
569 COLITIS 51 0.0013
570 PRODUCT DOSE OMISSION IN ERROR 38 0.0013
571 PRURITUS GENERALISED 29 0.0013
572 NERVOUSNESS 70 0.0013
573 EAR PAIN 26 0.0013
574 SKIN INFECTION 15 0.0013
575 MALAISE 585 0.0013
576 FREQUENT BOWEL MOVEMENTS 36 0.0013
577 PALPITATIONS 156 0.0013
578 CLOSTRIDIUM DIFFICILE INFECTION 29 0.0013
579 TOOTHACHE 24 0.0013
580 HEMIPLEGIA 11 0.0013
581 THERAPY CHANGE 13 0.0013
582 HYPOCALCAEMIA 25 0.0013
583 INFUSION SITE PAIN 17 0.0013
584 CONTUSION 127 0.0013
585 RHABDOMYOLYSIS 55 0.0013
586 PREMATURE DELIVERY 21 0.0013
587 EXOSTOSIS 12 0.0013
588 MUSCULOSKELETAL STIFFNESS 115 0.0013
589 HEART RATE INCREASED 130 0.0013
590 HAEMODIALYSIS 11 0.0013
591 PNEUMONIA BACTERIAL 12 0.0013
592 PROSTATIC SPECIFIC ANTIGEN INCREASED 18 0.0013
593 NEOPLASM 15 0.0013
594 BALANCE DISORDER 112 0.0013
595 PHARYNGITIS STREPTOCOCCAL 14 0.0013
596 CONTRAINDICATED PRODUCT ADMINISTERED 39 0.0013
597 MASS 18 0.0013
598 VASCULITIS 15 0.0013
599 COUGH 360 0.0013
600 MUSCLE SPASMS 235 0.0013
601 PAIN IN EXTREMITY 376 0.0013
602 BLOOD SODIUM DECREASED 24 0.0013
603 LYMPHOPENIA 18 0.0013
604 PNEUMONIA 412 0.0013
605 INJECTION SITE RASH 39 0.0013
606 BACK PAIN 295 0.0013
607 LETHARGY 73 0.0013
608 FRACTURE 24 0.0013
609 DYSSTASIA 37 0.0013
610 INITIAL INSOMNIA 13 0.0013
611 OXYGEN SATURATION DECREASED 71 0.0013
612 PERICARDIAL EFFUSION 29 0.0013
613 OROPHARYNGEAL PAIN 116 0.0013
614 GROIN PAIN 11 0.0013
615 HEPATITIS 32 0.0012
616 ORAL PAIN 28 0.0012
617 NEOPLASM MALIGNANT 83 0.0012
618 DRUG-INDUCED LIVER INJURY 39 0.0012
619 EAR INFECTION 33 0.0012
620 COMA 59 0.0012
621 MOBILITY DECREASED 89 0.0012
622 PERIPHERAL COLDNESS 17 0.0012
623 DEVICE BREAKAGE 50 0.0012
624 HAEMORRHOIDS 24 0.0012
625 BLOOD URINE PRESENT 23 0.0012
626 GASTRIC ULCER 23 0.0012
627 OFF LABEL USE 1059 0.0012
628 BRONCHITIS 89 0.0012
629 SYNCOPE 119 0.0012
630 INTERVERTEBRAL DISC DEGENERATION 11 0.0012
631 HEAD DISCOMFORT 21 0.0012
632 FATIGUE 923 0.0012
633 HYPOAESTHESIA 177 0.0012
634 DELIRIUM 41 0.0012
635 THINKING ABNORMAL 22 0.0012
636 ERYTHEMA MULTIFORME 11 0.0012
637 PARAESTHESIA ORAL 17 0.0012
638 TOOTH ABSCESS 12 0.0012
639 NEPHROLITHIASIS 54 0.0012
640 INTERSTITIAL LUNG DISEASE 57 0.0012
641 FOOT DEFORMITY 13 0.0012
642 MUSCLE TIGHTNESS 19 0.0012
643 TREATMENT NONCOMPLIANCE 64 0.0012
644 DYSURIA 43 0.0012
645 GAIT DISTURBANCE 223 0.0012
646 LUNG DISORDER 57 0.0012
647 TEMPERATURE INTOLERANCE 12 0.0012
648 SPINAL DISORDER 11 0.0012
649 HYPOTHYROIDISM 37 0.0012
650 HIATUS HERNIA 15 0.0012
651 TYPE 2 DIABETES MELLITUS 39 0.0012
652 PROTEINURIA 22 0.0012
653 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 54 0.0012
654 CARDIAC MURMUR 10 0.0012
655 BURSITIS 14 0.0012
656 ADRENAL INSUFFICIENCY 14 0.0012
657 SUPRAVENTRICULAR TACHYCARDIA 11 0.0011
658 HAEMATEMESIS 29 0.0011
659 CARDIOVASCULAR DISORDER 29 0.0011
660 DRY EYE 57 0.0011
661 FEELING ABNORMAL 273 0.0011
662 CARDIOMEGALY 14 0.0011
663 DISSEMINATED INTRAVASCULAR COAGULATION 16 0.0011
664 INTENTIONAL PRODUCT USE ISSUE 99 0.0011
665 DRUG INTERACTION 179 0.0011
666 CANDIDA INFECTION 19 0.0011
667 BLOOD PRESSURE FLUCTUATION 27 0.0011
668 STAPHYLOCOCCAL INFECTION 37 0.0011
669 SWELLING FACE 73 0.0011
670 FACIAL PAIN 10 0.0011
671 RED BLOOD CELL COUNT DECREASED 32 0.0011
672 OSTEOPOROSIS 46 0.0011
673 KNEE OPERATION 11 0.0011
674 SUBDURAL HAEMATOMA 16 0.0011
675 PHOTOPHOBIA 21 0.0011
676 POOR QUALITY SLEEP 24 0.0011
677 FEELING COLD 31 0.0011
678 DISTURBANCE IN ATTENTION 60 0.0011
679 FIBROMYALGIA 27 0.0011
680 HIP ARTHROPLASTY 17 0.0011
681 INSOMNIA 294 0.0011
682 DEPRESSION 251 0.0011
683 KNEE ARTHROPLASTY 23 0.0011
684 GASTROINTESTINAL PAIN 12 0.0011
685 THERAPY PARTIAL RESPONDER 17 0.0011
686 TINNITUS 50 0.0011
687 HEADACHE 678 0.0011
688 RASH GENERALISED 28 0.0011
689 HAEMATOMA 28 0.0011
690 SEPTIC SHOCK 47 0.0011
691 ARTHROPATHY 60 0.0011
692 EYE SWELLING 40 0.0011
693 SEIZURE 124 0.0011
694 DEVICE OCCLUSION 15 0.0011
695 INCORRECT PRODUCT STORAGE 14 0.0011
696 HEART RATE IRREGULAR 24 0.0011
697 TOOTH INFECTION 14 0.0011
698 HERPES ZOSTER 61 0.0011
699 SINUS DISORDER 21 0.0011
700 TENDERNESS 11 0.0011
701 HEART RATE DECREASED 37 0.0011
702 PRODUCT USE ISSUE 198 0.0011
703 MYALGIA 179 0.0011
704 INJURY 74 0.0011
705 JOINT RANGE OF MOTION DECREASED 14 0.0010
706 ALANINE AMINOTRANSFERASE INCREASED 64 0.0010
707 SUDDEN DEATH 11 0.0010
708 ILL-DEFINED DISORDER 63 0.0010
709 METASTASES TO BONE 17 0.0010
710 IMPAIRED HEALING 34 0.0010
711 SINUSITIS 106 0.0010
712 FEMUR FRACTURE 32 0.0010
713 IRRITABLE BOWEL SYNDROME 22 0.0010
714 SNEEZING 23 0.0010
715 MIDDLE INSOMNIA 19 0.0010
716 INABILITY TO AFFORD MEDICATION 10 0.0010
717 PRURITUS 384 0.0010
718 EMPHYSEMA 10 0.0010
719 URINARY RETENTION 33 0.0010
720 ABDOMINAL PAIN LOWER 25 0.0010
721 INJECTION SITE PRURITUS 66 0.0010
722 SARS-COV-2 TEST POSITIVE 13 0.0010
723 FOETAL EXPOSURE DURING PREGNANCY 80 0.0010
724 EYELID PTOSIS 10 0.0010
725 HERNIA 19 0.0010
726 HALLUCINATION 74 0.0010
727 MATERNAL EXPOSURE DURING PREGNANCY 87 0.0010
728 DYSPHONIA 57 0.0010
729 CHROMATURIA 22 0.0010
730 UNDERDOSE 71 0.0010
731 DEVICE USE ISSUE 17 0.0010
732 ARTHRALGIA 404 0.0010
733 BURNING SENSATION 68 0.0010
734 EXPOSURE DURING PREGNANCY 60 0.0010
735 COLD SWEAT 17 0.0010
736 SCAB 11 0.0010
737 AGEUSIA 24 0.0010
738 NIGHT SWEATS 31 0.0010
739 THROAT TIGHTNESS 26 0.0010
740 PSORIATIC ARTHROPATHY 39 0.0010
741 DEPRESSED LEVEL OF CONSCIOUSNESS 38 0.0010
742 LACRIMATION INCREASED 29 0.0010
743 CARDIO-RESPIRATORY ARREST 40 0.0010
744 BLOOD UREA INCREASED 16 0.0010
745 FEELING JITTERY 18 0.0009
746 BLISTER 53 0.0009
747 PAIN 579 0.0009
748 PRODUCT PHYSICAL ISSUE 19 0.0009
749 PRODUCT USE IN UNAPPROVED INDICATION 233 0.0009
750 SPLENOMEGALY 11 0.0009
751 WHITE BLOOD CELL COUNT INCREASED 36 0.0009
752 ACUTE RESPIRATORY FAILURE 18 0.0009
753 BODY HEIGHT DECREASED 10 0.0009
754 VIRAL INFECTION 31 0.0009
755 LIP SWELLING 31 0.0009
756 SKIN DISORDER 31 0.0009
757 BACTERAEMIA 11 0.0009
758 URTICARIA 155 0.0009
759 EYE PRURITUS 31 0.0009
760 BONE PAIN 54 0.0009
761 COGNITIVE DISORDER 43 0.0009
762 NODULE 12 0.0009
763 PYREXIA 318 0.0009
764 INFECTION 133 0.0009
765 MOOD ALTERED 25 0.0009
766 HAEMOGLOBIN DECREASED 94 0.0009
767 CHILLS 107 0.0009
768 UNEVALUABLE EVENT 69 0.0009
769 HEPATIC ENZYME INCREASED 62 0.0009
770 HAEMATOCHEZIA 50 0.0009
771 LYMPHOMA 14 0.0009
772 ADVERSE REACTION 12 0.0009
773 JOINT SWELLING 109 0.0009
774 HOT FLUSH 68 0.0009
775 EJECTION FRACTION DECREASED 14 0.0009
776 RASH MACULO-PAPULAR 20 0.0009
777 SWOLLEN TONGUE 28 0.0009
778 ENCEPHALOPATHY 22 0.0009
779 CYST 11 0.0009
780 HEPATIC FUNCTION ABNORMAL 33 0.0009
781 HAIR COLOUR CHANGES 11 0.0009
782 SKIN CANCER 19 0.0009
783 EPISTAXIS 66 0.0009
784 THERAPY INTERRUPTED 63 0.0009
785 RESPIRATORY TRACT CONGESTION 14 0.0009
786 OBESITY 14 0.0009
787 ANXIETY 250 0.0009
788 DERMATITIS CONTACT 10 0.0009
789 JOINT STIFFNESS 23 0.0009
790 LYMPHADENOPATHY 31 0.0009
791 CHOKING 17 0.0009
792 SKIN DISCOLOURATION 40 0.0009
793 ARRHYTHMIA 41 0.0009
794 IRRITABILITY 52 0.0009
795 PULMONARY HYPERTENSION 18 0.0009
796 PLATELET COUNT DECREASED 92 0.0009
797 DISORIENTATION 34 0.0009
798 HAEMATOCRIT DECREASED 17 0.0009
799 METASTASES TO LIVER 15 0.0009
800 RASH 368 0.0008
801 OCULAR HYPERAEMIA 40 0.0008
802 ECZEMA 44 0.0008
803 ISCHAEMIC STROKE 15 0.0008
804 CEREBRAL HAEMORRHAGE 30 0.0008
805 ANHEDONIA 22 0.0008
806 PRODUCT AVAILABILITY ISSUE 19 0.0008
807 PULMONARY CONGESTION 11 0.0008
808 RASH MACULAR 29 0.0008
809 LEUKOCYTOSIS 15 0.0008
810 MENTAL STATUS CHANGES 23 0.0008
811 MENTAL DISORDER 36 0.0008
812 PRODUCT PRESCRIBING ISSUE 18 0.0008
813 FLUID OVERLOAD 12 0.0008
814 MUSCLE TWITCHING 19 0.0008
815 PNEUMOTHORAX 13 0.0008
816 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 19 0.0008
817 INJECTION SITE REACTION 56 0.0008
818 PAIN IN JAW 23 0.0008
819 TOOTH DISORDER 18 0.0008
820 HYPOTENSION 162 0.0008
821 BLOOD ALKALINE PHOSPHATASE INCREASED 20 0.0008
822 DRUG INEFFECTIVE 1059 0.0008
823 THROAT IRRITATION 36 0.0008
824 EYE IRRITATION 46 0.0008
825 HYPOAESTHESIA ORAL 12 0.0008
826 RESPIRATORY FAILURE 58 0.0008
827 BREAST CANCER 74 0.0008
828 BRAIN OEDEMA 10 0.0008
829 ORAL DISCOMFORT 11 0.0008
830 STOMATITIS 48 0.0008
831 PARAESTHESIA 124 0.0008
832 CARDIAC ARREST 65 0.0008
833 GASTRIC DISORDER 27 0.0008
834 CHOLESTASIS 15 0.0008
835 PHARYNGEAL OEDEMA 12 0.0008
836 ANAPHYLACTIC REACTION 43 0.0008
837 MELAENA 17 0.0008
838 DIPLOPIA 20 0.0008
839 BASAL CELL CARCINOMA 12 0.0008
840 RESPIRATORY DISORDER 23 0.0008
841 PANIC ATTACK 28 0.0008
842 RESPIRATORY TRACT INFECTION 20 0.0008
843 HEMIPARESIS 13 0.0008
844 RESTLESSNESS 28 0.0008
845 DERMATITIS 16 0.0008
846 APATHY 11 0.0008
847 PRESCRIBED UNDERDOSE 15 0.0008
848 LABORATORY TEST ABNORMAL 22 0.0007
849 DRUG EFFECT LESS THAN EXPECTED 11 0.0007
850 SKIN HAEMORRHAGE 11 0.0007
851 COLITIS ULCERATIVE 33 0.0007
852 HYPERSENSITIVITY 137 0.0007
853 BRADYCARDIA 39 0.0007
854 PALLOR 20 0.0007
855 DRUG ERUPTION 13 0.0007
856 MIGRAINE 70 0.0007
857 APHASIA 22 0.0007
858 VENTRICULAR TACHYCARDIA 12 0.0007
859 DRUG LEVEL INCREASED 12 0.0007
860 OSTEOPENIA 11 0.0007
861 RECTAL HAEMORRHAGE 31 0.0007
862 INJECTION SITE SWELLING 55 0.0007
863 DYSARTHRIA 27 0.0007
864 SKIN FISSURES 14 0.0007
865 MOVEMENT DISORDER 23 0.0007
866 DRUG DOSE OMISSION BY DEVICE 56 0.0007
867 VAGINAL HAEMORRHAGE 31 0.0007
868 RASH PAPULAR 16 0.0007
869 RENAL INJURY 21 0.0007
870 JAUNDICE 19 0.0007
871 PSORIASIS 92 0.0007
872 ALOPECIA 138 0.0007
873 IMPAIRED WORK ABILITY 15 0.0007
874 DRUG DOSE OMISSION 115 0.0007
875 DYSPHAGIA 66 0.0007
876 INTENTIONAL SELF-INJURY 14 0.0007
877 RASH ERYTHEMATOUS 33 0.0007
878 C-REACTIVE PROTEIN INCREASED 25 0.0007
879 DYSGEUSIA 51 0.0007
880 LUNG NEOPLASM MALIGNANT 28 0.0007
881 SUICIDAL IDEATION 62 0.0007
882 CARDIOMYOPATHY 10 0.0007
883 TOOTH LOSS 14 0.0007
884 ABORTION SPONTANEOUS 27 0.0007
885 THERAPEUTIC PRODUCT EFFECT DECREASED 30 0.0007
886 HALLUCINATION, VISUAL 14 0.0007
887 PNEUMONITIS 18 0.0007
888 INFLAMMATION 34 0.0007
889 SPEECH DISORDER 34 0.0006
890 ERYTHEMA 132 0.0006
891 NERVOUS SYSTEM DISORDER 20 0.0006
892 DYSKINESIA 26 0.0006
893 MUSCULOSKELETAL DISORDER 12 0.0006
894 HALLUCINATION, AUDITORY 10 0.0006
895 WHITE BLOOD CELL COUNT DECREASED 68 0.0006
896 EPILEPSY 19 0.0006
897 NEUTROPHIL COUNT DECREASED 25 0.0006
898 MUSCULOSKELETAL PAIN 32 0.0006
899 INJECTION SITE ERYTHEMA 75 0.0006
900 BONE DISORDER 11 0.0006
901 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 11 0.0006
902 DEEP VEIN THROMBOSIS 39 0.0006
903 AGGRESSION 30 0.0006
904 GASTROINTESTINAL HAEMORRHAGE 50 0.0006
905 FULL BLOOD COUNT DECREASED 12 0.0006
906 FEELING HOT 36 0.0006
907 DEATH 502 0.0006
908 RESPIRATORY DISTRESS 16 0.0006
909 ABNORMAL DREAMS 16 0.0006
910 RHEUMATOID ARTHRITIS 65 0.0006
911 MOUTH ULCERATION 12 0.0006
912 PRESCRIBED OVERDOSE 11 0.0006
913 ORAL HERPES 11 0.0006
914 THERAPEUTIC RESPONSE DECREASED 34 0.0006
915 FEAR 15 0.0006
916 BLOOD BILIRUBIN INCREASED 15 0.0006
917 SKIN LESION 15 0.0005
918 GAMMA-GLUTAMYLTRANSFERASE INCREASED 12 0.0005
919 PROCEDURAL PAIN 15 0.0005
920 MENTAL IMPAIRMENT 13 0.0005
921 GLOSSODYNIA 12 0.0005
922 THERAPY NON-RESPONDER 24 0.0005
923 HEPATIC FAILURE 16 0.0005
924 MALIGNANT NEOPLASM PROGRESSION 54 0.0005
925 THERAPY CESSATION 27 0.0005
926 DRY SKIN 70 0.0005
927 INFLUENZA LIKE ILLNESS 43 0.0005
928 FLUSHING 53 0.0005
929 BLOOD CREATINE PHOSPHOKINASE INCREASED 15 0.0005
930 ANGIOEDEMA 23 0.0005
931 PLASMA CELL MYELOMA 20 0.0005
932 THERAPEUTIC RESPONSE SHORTENED 17 0.0005
933 AGITATION 37 0.0005
934 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 17 0.0005
935 EXPOSURE VIA SKIN CONTACT 13 0.0005
936 PANCYTOPENIA 28 0.0005
937 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 35 0.0005
938 THERAPEUTIC RESPONSE UNEXPECTED 22 0.0005
939 ADVERSE DRUG REACTION 44 0.0005
940 GASTRIC CANCER 12 0.0005
941 CRYING 17 0.0005
942 ANAPHYLACTIC SHOCK 12 0.0005
943 UNRESPONSIVE TO STIMULI 12 0.0005
944 NIGHTMARE 16 0.0005
945 SYSTEMIC LUPUS ERYTHEMATOSUS 16 0.0005
946 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 32 0.0004
947 PAIN OF SKIN 12 0.0004
948 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 24 0.0004
949 RESPIRATORY ARREST 12 0.0004
950 ACNE 33 0.0004
951 ANGER 14 0.0004
952 MEDICATION ERROR 23 0.0004
953 MOOD SWINGS 13 0.0004
954 SKIN BURNING SENSATION 29 0.0004
955 EXTRAPYRAMIDAL DISORDER 10 0.0004
956 PRODUCT SUBSTITUTION ISSUE 23 0.0004
957 DISEASE RECURRENCE 19 0.0004
958 VISUAL ACUITY REDUCED 13 0.0004
959 SKIN EXFOLIATION 33 0.0004
960 ERECTILE DYSFUNCTION 10 0.0004
961 EMOTIONAL DISTRESS 47 0.0004
962 INTERNATIONAL NORMALISED RATIO INCREASED 11 0.0004
963 OVERDOSE 83 0.0004
964 THROMBOCYTOPENIA 43 0.0004
965 TACHYCARDIA 34 0.0004
966 INFUSION RELATED REACTION 25 0.0004
967 ABNORMAL BEHAVIOUR 14 0.0004
968 NEUTROPENIA 48 0.0004
969 DEVICE USE ERROR 12 0.0003
970 NEOPLASM PROGRESSION 12 0.0003
971 TOXICITY TO VARIOUS AGENTS 58 0.0003
972 RENAL CANCER 16 0.0003
973 DEVICE DIFFICULT TO USE 22 0.0003
974 ACCIDENTAL EXPOSURE TO PRODUCT 34 0.0003
975 ADVERSE EVENT 30 0.0003
976 DRUG EFFECT DECREASED 17 0.0003
977 ELECTROCARDIOGRAM QT PROLONGED 11 0.0003
978 SKIN IRRITATION 14 0.0003
979 DERMATITIS ATOPIC 16 0.0003
980 DEVICE DISLOCATION 13 0.0003
981 DISEASE PROGRESSION 34 0.0003
982 PROSTATE CANCER 23 0.0003
983 MULTIPLE SCLEROSIS RELAPSE 19 0.0003
984 DRUG EFFECT INCOMPLETE 10 0.0003
985 WITHDRAWAL SYNDROME 11 0.0003
986 MULTIPLE SCLEROSIS 11 0.0002
987 BLADDER CANCER 13 0.0002
988 NO ADVERSE EVENT 33 0.0002
989 TREATMENT FAILURE 15 0.0002
990 COMPLETED SUICIDE 14 0.0002
991 DRUG ABUSE 13 0.0002
992 DRUG DEPENDENCE 10 0.0001